These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14742226)

  • 1. Moxifloxacin penetration in bronchial secretions of mechanically ventilated patients with pneumonia.
    Leone M; Albanèse J; Sampol-Manos E; Simon N; Lacarelle B; Bruguerolle B; Martin C
    Antimicrob Agents Chemother; 2004 Feb; 48(2):638-40. PubMed ID: 14742226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
    Simon N; Sampol E; Albanese J; Martin C; Arvis P; Urien S; Lacarelle B; Bruguerolle B
    Clin Pharmacol Ther; 2003 Oct; 74(4):353-63. PubMed ID: 14534522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.
    Gardner SY; Davis JL; Jones SL; LaFevers DH; Hoskins MS; McArver EM; Papich MG
    J Vet Pharmacol Ther; 2004 Feb; 27(1):57-60. PubMed ID: 14995968
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.
    Abd El-Aty AM; Goudah A; Shah SS; Shin HC; Shimoda M; Shim JH
    J Vet Pharmacol Ther; 2007 Dec; 30(6):586-91. PubMed ID: 17991229
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
    Rink AD; Stass H; Delesen H; Kubitza D; Vestweber KH
    Clin Drug Investig; 2008; 28(2):71-9. PubMed ID: 18211115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration and accumulation of moxifloxacin in uterine tissue.
    Stass H; Kubitza D; Aydeniz B; Wallwiener D; Halabi A; Gleiter C
    Int J Gynaecol Obstet; 2008 Aug; 102(2):132-6. PubMed ID: 18501909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
    Kim DH; Stark WJ; O'Brien TP
    Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
    Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
    Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis.
    Skalioti C; Tsaganos T; Stamatiadis D; Giamarellos-Bourboulis EJ; Boletis J; Kanellakopoulou K
    Perit Dial Int; 2009; 29(5):575-9. PubMed ID: 19776053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition kinetics of moxifloxacin in lactating ewes.
    Goudah A
    Vet J; 2008 Nov; 178(2):282-7. PubMed ID: 17900948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations.
    Goudah A; Hasabelnaby S
    Chemotherapy; 2010; 56(1):26-31. PubMed ID: 20197659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study.
    de Smet J; Colpaert K; de Paepe P; van Bocxlaer J; Decruyenaere J; Boussery K
    Scand J Infect Dis; 2012 Nov; 44(11):874-8. PubMed ID: 22804100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
    Lindstrom R; Lane S; Cottingham A; Smith S; Sall K; Silverstein S; Shettle L; Walters T; Faulkner R; Cockrum P; Teuscher N
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.
    Cárceles CM; Villamayor L; Escudero E; Marín P; Fernández-Varón E
    Vet J; 2007 Mar; 173(2):452-5. PubMed ID: 16377219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.
    Matsuura K
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):1019-20. PubMed ID: 22552573
    [No Abstract]   [Full Text] [Related]  

  • 17. Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patients.
    Kees MG; Schaeftlein A; Haeberle HA; Kees F; Kloft C; Heininger A
    J Antimicrob Chemother; 2013 Jun; 68(6):1331-7. PubMed ID: 23463212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.
    Majcher-Peszynska J; Sass M; Schipper S; Czaika V; Gussmann A; Lobmann R; Mundkowski RG; Luebbert C; Kujath P; Ruf BR; Koch H; Schareck W; Klar E; Drewelow B;
    Eur J Clin Pharmacol; 2011 Feb; 67(2):135-42. PubMed ID: 20871984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers.
    Kanjanawart S; Gaysonsiri D; Phunikom K; Simasathiansopon S; Tangsucharit P; Vannaprasaht S; Kaewkamson T; Tassaneeyakul W
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):249-54. PubMed ID: 23357835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.
    Kees MG; Weber S; Kees F; Horbach T
    J Antimicrob Chemother; 2011 Oct; 66(10):2330-5. PubMed ID: 21729931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.